Dr Ajeet Singh

STAFF PROFILE

Position

Clinical Associate Professor

Faculty

Faculty of Health

Department

School of Medicine

Campus

Off-Campus (Home)

Publications

Filter by

2021

The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders

G Malhi, E Bell, D Bassett, P Boyce, R Bryant, P Hazell, M Hopwood, B Lyndon, R Mulder, R Porter, A Singh, G Murray

(2021), Vol. 55, pp. 7-117, Australian and New Zealand Journal of Psychiatry, London, Eng., C1

journal article
2020

Personality disorder and functioning in major depressive disorder: a nested study within a randomized controlled trial

Bianca Kavanagh, Lana Williams, Michael Berk, Alyna Turner, Henry Jackson, Mohammadreza Mohebbi, Buranee Kanchanatawan, Melanie Ashton, Chee Ng, Michael Maes, Lesley Berk, Gin Malhi, Nathan Dowling, Ajeet Singh, Olivia Dean

(2020), Vol. 42, pp. 14-21, Brazilian journal of psychiatry, Sao Paulo, Brazil, C1

journal article

A pragmatic randomized controlled trial exploring the relationship between pulse number and response to repetitive transcranial magnetic stimulation treatment in depression

P Fitzgerald, K Hoy, J Reynolds, A Singh, R Gunewardene, C Slack, S Ibrahim, Z Daskalakis

(2020), Vol. 13, pp. 145-152, Brain stimulation, Amsterdam, The Netherlands, C1

journal article

Switching antidepressants in the treatment of major depression: when, how and what to switch to?

P Boyce, M Hopwood, G Morris, A Hamilton, D Bassett, B Baune, R Mulder, R Porter, G Parker, A Singh, T Outhred, P Das, G Malhi

(2020), Vol. 261, pp. 160-163, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal article

Acute coronary syndrome-associated depression: getting to the heart of the data

G Parker, D Bassett, P Boyce, B Lyndon, R Mulder, R Porter, A Singh, E Bell, A Hamilton, G Morris, M Spoelma, G Malhi

(2020), Vol. 269, pp. 70-77, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal article

The protective effects of human milk-derived peptides on the pancreatic islet biology

Amitoj Singh, Ashwantha Enjapoori, Yann Gibert, Karen Dwyer

(2020), Vol. 9, pp. 1-20, Biology Open, Cambridge, Eng., C1

journal article

Minocycline as adjunctive treatment for major depressive disorder: Pooled data from two randomized controlled trials

R Zazula, M Husain, M Mohebbi, A Walker, I Chaudhry, A Khoso, M Ashton, B Agustini, N Husain, J Deakin, A Young, M Berk, B Kanchanatawan, C Ng, M Maes, L Berk, A Singh, G Malhi, O Dean

(2020), pp. 1-15, Australian and New Zealand Journal of Psychiatry, London, Eng., C1

journal article

The 2020 Royal Australian and New Zealand College of psychiatrists clinical practice guidelines for mood disorders: Bipolar disorder summary

G Malhi, E Bell, P Boyce, D Bassett, M Berk, R Bryant, M Gitlin, A Hamilton, P Hazell, M Hopwood, B Lyndon, R McIntyre, G Morris, R Mulder, R Porter, A Singh, L Yatham, A Young, G Murray

(2020), Vol. 22, pp. 805-821, Bipolar Disorders, London, Eng., C1

journal article

The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders: Major depression summary

G Malhi, E Bell, A Singh, D Bassett, M Berk, P Boyce, R Bryant, M Gitlin, A Hamilton, P Hazell, M Hopwood, B Lyndon, R McIntyre, G Morris, R Mulder, R Porter, L Yatham, A Young, G Murray

(2020), Vol. 22, pp. 788-804, Bipolar Disorders, London, Eng., C1

journal article

Cognitive side-effects of electroconvulsive therapy: what are they, how to monitor them and what to tell patients

Richard Porter, Bernhard Baune, Grace Morris, Amber Hamilton, Darryl Bassett, Philip Boyce, Malcolm Hopwood, Roger Mulder, Gordon Parker, Ajeet Singh, Tim Outhred, Pritha Das, Gin Malhi

(2020), Vol. 6, pp. 1-7, BJPsych open, Cambridge, Eng., C1

journal article
2019

The role of depression pharmacogenetic decision support tools in shared decision making

K Arandjelovic, H Eyre, E Lenze, A Singh, M Berk, C Bousman

(2019), Vol. 126, pp. 87-94, Journal of neural transmission, Vienna, Austria, C1

journal article

Moving pharmacoepigenetics tools for depression toward clinical use

Laura Hack, Gabriel Fries, Harris Eyre, Chad Bousman, Ajeet Singh, Joao Quevedo, Vineeth John, Bernhard Baune, Boadie Dunlop

(2019), Vol. 249, pp. 336-346, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal article

Stepwise treatment of acute bipolar depression

G Parker, G Malhi, A Hamilton, G Morris, G Tavella, D Bassett, B Baune, P Boyce, M Hopwood, R Mulder, R Porter, T Outhred, P Das, A Singh

(2019), Vol. 21, pp. 465-469, Bipolar disorders, Chichester, Eng., C1

journal article
2018

The limitations of using randomised controlled trials as a basis for developing treatment guidelines

R Mulder, A Singh, A Hamilton, P Das, T Outhred, G Morris, D Bassett, B Baune, M Berk, P Boyce, B Lyndon, G Parker, G Malhi

(2018), Vol. 21, pp. 4-6, Evidence-based mental health, London, Eng., C1

journal article

Cognition in depression: can we THINC-it better?

B Baune, G Malhi, G Morris, T Outhred, A Hamilton, P Das, D Bassett, M Berk, P Boyce, B Lyndon, R Mulder, G Parker, A Singh

(2018), Vol. 225, pp. 559-562, Journal of affective disorders, Amsterdam, The Netherlands, C1

journal article

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders: bipolar disorder summary.

Gin Malhi, Tim Outhred, Grace Morris, Philip Boyce, Richard Bryant, Paul Fitzgerald, Malcolm Hopwood, Bill Lyndon, Roger Mulder, Greg Murray, Richard Porter, Ajeet Singh, Kristina Fritz

(2018), Vol. 208, pp. 219-225, Medical journal of Australia, London, Eng., C1

journal article

Pharmacogenetic guidelines and decision support tools for depression treatment: application to late-life

Donald Chang, Harris Eyreeuro, Ryan Abbott, Michael Coudreaut, Bernhard Baune, Jeffrey Shaman, Helen Lavretsky, Eric Lenze, David Merrill, Ajeet Singh, Benoit Mulsant, Charles Reynolds, Daniel Müller, Chad Bousman

(2018), Vol. 19, pp. 1269-1284, Pharmacogenomics, London, Eng., C1

journal article
2017

Beyond the therapeutic shackles of the monoamines: new mechanisms in bipolar disorder biology

J Data-Franco, A Singh, D Popovic, M Ashton, M Berk, E Vieta, M Figueira, O Dean

(2017), Vol. 72, pp. 73-86, Progress in neuro-psychopharmacology & biological psychiatry, Amsterdam, The Netherlands, C1

journal article

Concordance between actual and pharmacogenetic predicted desvenlafaxine dose needed to achieve remission in major depressive disorder: a 10-week open-label study

C Bousman, D Müller, C Ng, K Byron, M Berk, A Singh

(2017), Vol. 27, pp. 1-6, Pharmacogenetics and genomics, London, Eng., C1

journal article

Adjunctive minocycline treatment for major depressive disorder: a proof of concept trial

O Dean, B Kanchanatawan, M Ashton, M Mohebbi, C Ng, M Maes, L Berk, A Sughondhabirom, S Tangwongchai, A Singh, H McKenzie, D Smith, G Malhi, N Dowling, M Berk

(2017), Vol. 51, pp. 829-840, Australian & New Zealand journal of psychiatry, London, Eng., C1

journal article

Defining melancholia: a core mood disorder

G Parker, D Bassett, T Outhred, G Morris, A Hamilton, P Das, B Baune, M Berk, P Boyce, B Lyndon, R Mulder, A Singh, G Malhi

(2017), Vol. 19, pp. 235-237, Bipolar disorders, London, Eng., C1

journal article

Psychotropic pharmacogenetics - distraction or destiny?

A Singh, B Baune, A Hamilton, P Das, T Outhred, G Morris, D Bassett, M Berk, P Boyce, B Lyndon, R Mulder, G Parker, G Malhi

(2017), Vol. 51, pp. 665-667, Australian & New Zealand journal of psychiatry, London, Eng., C1

journal article

Mixed mood: the not so united states?

G Malhi, M Berk, G Morris, A Hamilton, T Outhred, P Das, D Bassett, B Baune, P Boyce, B Lyndon, R Mulder, G Parker, A Singh

(2017), Vol. 19, pp. 242-245, Bipolar Disorders, Hoboken, N. J., C1

journal article

Staging in bipolar disorder: from theoretical framework to clinical utility

M Berk, R Post, A Ratheesh, E Gliddon, A Singh, E Vieta, A Carvalho, M Ashton, L Berk, S Cotton, P McGorry, B Fernandes, L Yatham, S Dodd

(2017), Vol. 16, pp. 236-244, World psychiatry, Chichester, Eng., C1

journal article
2016

Stimulants for depression: On the up and up?

G Malhi, Y Byrow, D Bassett, P Boyce, M Hopwood, W Lyndon, R Mulder, R Porter, A Singh, G Murray

(2016), Vol. 50, pp. 203-207, Australian & New Zealand journal of psychiatry, London, Eng., C1

journal article

Why the hype about subtype? Bipolar I, bipolar II - it's simply bipolar, through and through!

G Malhi, Y Byrow, P Boyce, D Bassett, P Fitzgerald, M Hopwood, W Lyndon, R Mulder, G Murray, A Singh, R Bryant, R Porter

(2016), Vol. 50, pp. 303-306, Australian & New Zealand journal of psychiatry, London, Eng., C1

journal article

Mental health system development in Asia: does Australia have a role?

K Arandjelovic, H Eyre, M Forbes, R Bauer, S Aggarwal, A Singh, B Baune, I Everall, M Berk, C Ng

(2016), Vol. 50, pp. 834-841, Australian & New Zealand journal of psychiatry, London, Eng., C1

journal article
2015

A brief review of exercise, bipolar disorder, and mechanistic pathways.

D Thomson, A Turner, S Lauder, M Gigler, L Berk, A Singh, J Pasco, M Berk, L Sylvia

(2015), Vol. 6, pp. 147-147, Frontiers in Psychology, Switzerland, C1

journal article

Homocysteine as a potential biomarker in bipolar disorders: a critical review and suggestions for improved studies

A Ghanizadeh, A Singh, M Berk, M Torabi-Nami

(2015), Vol. 19, pp. 1-13, Expert opinion on therapeutic targets, Oxford, Eng., C1

journal article

Effects of persisting emotional impact from child abuse and norepinephrine transporter genetic variation on antidepressant efficacy in major depression: a pilot study

A Singh, C Bousman, C Ng, K Byron, M Berk

(2015), Vol. 13, pp. 53-61, Clinical psychopharmacology and neuroscience, Korea (South), C1

journal article

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders

G Malhi, D Bassett, P Boyce, R Bryant, P Fitzgerald, K Fritz, M Hopwood, B Lyndon, R Mulder, G Murray, R Porter, A Singh

(2015), Vol. 49, pp. 1087-1206, Australian and New Zealand journal of psychiatry, Carlton South, Vic., C1

journal article
2014

Antidepressant pharmacogenetics

A Singh, C Bousman, C Ng, M Berk

(2014), Vol. 27, pp. 43-51, Current Opinion in Psychiatry, C1

journal article

Escitalopram efficacy in depression a cross-ethnicity examination of the serotonin transporter promoter polymorphism

C Bousman, J Sarris, E Won, H Chang, A Singh, H Lee, B Ham, C Tan, M Lee, C Ng

(2014), Vol. 34, pp. 1-4, Journal of clinical psychopharmacology, London, England, C1

journal article

Atypical antipsychotic agents; peas in a pod or chalk and cheese?

A Singh, A Nierenberg, L Yatham, M Berk

(2014), Vol. 12, pp. 1-4, BMC Medicine, London, England, C1

journal article

High-impact child abuse may predict risk of elevated suicidality during antidepressant initiation

A Singh, C Bousman, C Ng, M Berk

(2014), Vol. 48, pp. 124-124, RANZCP 2014 : Evolving landscapes in mental health: interface & interaction : Proceedings of Congress 2014, Perth, W.A., E1-1

conference
2013

Psychomotor depressive symptoms may differentially respond to venlafaxine

A Singh, C Bousman, C Ng, K Byron, M Berk

(2013), Vol. 28, pp. 121-126, International clinical psychopharmacology, Philadelphia, Pa., C1

journal article

High impact child abuse may predict risk of elevated suicidality during antidepressant initiation

A Singh, C Bousman, C Ng, M Berk

(2013), Vol. 47, pp. 1191-1195, Australian & New Zealand journal of psychiatry, London, Eng., C1-1

journal article

Pharmacogenetic polymorphisms and response to escitalopram and venlafaxine over 8 weeks in major depression

C Ng, J Sarris, A Singh, C Bousman, K Byron, L Peh, D Smith, C Tan, I Schweitzer

(2013), Vol. 28, pp. 516-522, Human psychopharmacology: clinical and experimental, Chichester, Eng., C1-1

journal article

Equivalent beneficial effects of unilateral and bilateral prefrontal cortex transcranial magnetic stimulation in a large randomized trial in treatment-resistant major depression

P Fitzgerald, K Hoy, A Singh, R Gunewardene, C Slack, S Ibrahim, P Hall, Z Daskalakis

(2013), Vol. 16, pp. 1975-1984, International journal of neuropsychopharmacology, Oxford, Eng., C1-1

journal article
2012

ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression

A Singh, C Bousman, C Ng, K Byron, M Berk

(2012), Vol. 2, Translational Psychiatry, C1

journal article
2011

A consensus statement for safety monitoring guidelines of treatments for major depressive disorder

S Dodd, G Malhi, J Tiller, I Schweitzer, I Hickie, J Khoo, D Bassett, B Lyndon, P Mitchell, G Parker, P Fitzgerald, M Udina, A Singh, S Moylan, F Giorlando, C Doughty, C Davey, M Theodoros, M Berk

(2011), Vol. 45, pp. 712-725, Australian and New Zealand Journal of Psychiatry, C1

journal article
2003

Summary of Guideline for the Treatment of Bipolar Disorder

Philip Mitchell, Gin Malhi, Bernette Redwood, Jillian Ball

(2003), Vol. 11, pp. 39-53, Australasian Psychiatry, C1-1

journal article

Funded Projects at Deakin

Industry and Other Funding

Do Blood Brain Barrier & Hepatic Enzyme Polymorphisms Predict Antidepressant Dose? A Candidate Gene Association Study.

Dr Ajeet Singh

  • 2012: $37,126

Supervisions

No completed student supervisions to report